A Multi-domain and Multi-component Falls Intervention Program for Community- Dwelling Older Adults: SAFE-TECH
Launched by DUKE-NUS GRADUATE MEDICAL SCHOOL · Oct 22, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The SAFE-TECH study is focused on finding better ways to prevent falls and injuries from falls in older adults who live in the community and are at higher risk. Falls can lead to serious injuries and a lower quality of life, so this trial aims to use new technology, like wearable devices, to identify those at risk and provide a personalized falls prevention program. Participants will go through a 12-week program that includes exercise and education, with feedback tailored to their individual needs to help them stay safe and active.
To be eligible for the study, participants should be between 60 and 95 years old, able to walk with or without assistance, and must not have significant cognitive impairment. They should also be in good overall health, meaning they haven't had serious health issues like heart failure or strokes in the past six months. This trial is currently recruiting participants, and anyone interested should be prepared to complete a simple walking assessment at the beginning of the study. By joining this program, participants can expect to gain valuable tools to help reduce their risk of falls and improve their overall well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 60 to 95 years
- • Ambulatory with or without walking aid
- • Does not possess cognitive impairment with an Abbreviated Mental Score-Singapore \>=6
- Exclusion Criteria:
- * Had any significant morbidity:
- • Congestive Heart Failure in the past 6 months
- • Myocardial Infarction in the past 6 months
- • Stroke (Intra-Cranial Haemorrhage) in the past 6 months
- • Concussion or Head Injury in the past 6 months
- • End Stage Renal Failure requiring dialysis
- • Severe Asthma or Chronic Obstructive Pulmonary Disease (COPD) (e.g. Chronic Lung Disease or Chronic Bronchitis or Emphysema), experiencing symptoms at rest or with mild activity
- • Lower Limb Fractures in the past 6 months
- • Blindness, with or without the use of any visual aids
- • Deafness, with or without the use of any hearing aids
- * Currently experiencing one of the following:
- • Chest discomfort, or
- • Breathlessness, or
- • Dizziness, or
- • Profuse sweating
- • Had an amputation of any part of the lower limbs except toes, or had an amputation of any toes in the last 30 days
- • Currently in a long-term institution
- • Currently participating in any randomized clinical or controlled trial that involves physical exercise
- • Unwilling to complete the baseline gait assessment, or complete less than 3 minutes of the 5-minute baseline gait assessment
About Duke Nus Graduate Medical School
Duke-NUS Graduate Medical School is a leading biomedical research institution located in Singapore, renowned for its commitment to advancing medical education, research, and healthcare innovation. As a partnership between Duke University in the United States and the National University of Singapore, the school emphasizes a collaborative approach to tackling pressing health challenges through cutting-edge clinical trials and interdisciplinary research. With a focus on translating scientific discoveries into practical applications, Duke-NUS plays a pivotal role in shaping the future of medicine and healthcare in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Matchar David Bruce
Principal Investigator
Duke-NUS Graduate Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported